TSE-424 vs. Raloxifene Activity on Bone Markers
Percent
Decrease
in Bone
Markers
Data from AHP’s Analyst Meeting 5/16/01
Raloxifene
60 mg.
TSE-424
20 mg.
TSE-424
40 mg.
P = .001 for All Treatments Relative to Placebo
Results of Phase II Study
Previous slide
Next slide
Back to first slide
View graphic version